rs16825565
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_012387.3(PADI4):c.723C>T(p.Pro241Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00265 in 1,613,862 control chromosomes in the GnomAD database, including 103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 55 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 48 hom. )
Consequence
PADI4
NM_012387.3 synonymous
NM_012387.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -12.5
Publications
4 publications found
Genes affected
PADI4 (HGNC:18368): (peptidyl arginine deiminase 4) This gene is a member of a gene family which encodes enzymes responsible for the conversion of arginine residues to citrulline residues. This gene may play a role in granulocyte and macrophage development leading to inflammation and immune response. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 1-17342013-C-T is Benign according to our data. Variant chr1-17342013-C-T is described in ClinVar as [Benign]. Clinvar id is 782905.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-12.5 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0139 (2116/152258) while in subpopulation AFR AF = 0.0481 (2000/41540). AF 95% confidence interval is 0.0464. There are 55 homozygotes in GnomAd4. There are 983 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 55 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0138 AC: 2105AN: 152140Hom.: 55 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2105
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00350 AC: 879AN: 251364 AF XY: 0.00252 show subpopulations
GnomAD2 exomes
AF:
AC:
879
AN:
251364
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00148 AC: 2168AN: 1461604Hom.: 48 Cov.: 31 AF XY: 0.00127 AC XY: 922AN XY: 727118 show subpopulations
GnomAD4 exome
AF:
AC:
2168
AN:
1461604
Hom.:
Cov.:
31
AF XY:
AC XY:
922
AN XY:
727118
show subpopulations
African (AFR)
AF:
AC:
1734
AN:
33476
American (AMR)
AF:
AC:
98
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26132
East Asian (EAS)
AF:
AC:
1
AN:
39688
South Asian (SAS)
AF:
AC:
7
AN:
86250
European-Finnish (FIN)
AF:
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
AC:
13
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
141
AN:
1111762
Other (OTH)
AF:
AC:
173
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
103
206
310
413
516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0139 AC: 2116AN: 152258Hom.: 55 Cov.: 32 AF XY: 0.0132 AC XY: 983AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
2116
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
983
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
2000
AN:
41540
American (AMR)
AF:
AC:
75
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3462
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14
AN:
68018
Other (OTH)
AF:
AC:
25
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
99
199
298
398
497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 17, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.